5 C
New York
Monday, February 6, 2023

Subscribe

Moderna’s mRNA RSV vaccine delivers impressive Phase 3 trial results

Biotechnology company Moderna has announced promising results from its massive Phase 3 trial testing an mRNA vaccine for respiratory syncytial virus …

This post was originally published on this site

Subscribe
Notify of
0 Comments
Inline Feedbacks
View all comments

Stay Connected

159,283FansLike
406,828FollowersFollow
2,160SubscribersSubscribe

Latest Articles

0
Would love your thoughts, please comment.x
()
x